International Stem Cell Corp (ISCO)
0.065
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
International Stem Cell Cash from Operations (TTM): 0.929M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.929M |
| September 30, 2023 | 0.847M |
| June 30, 2023 | 0.869M |
| March 31, 2023 | 0.571M |
| December 31, 2022 | 0.332M |
| September 30, 2022 | -0.063M |
| June 30, 2022 | -0.371M |
| March 31, 2022 | -0.926M |
| December 31, 2021 | -1.297M |
| September 30, 2021 | -1.292M |
| June 30, 2021 | -1.345M |
| March 31, 2021 | -1.00M |
| December 31, 2020 | -0.341M |
| September 30, 2020 | -0.411M |
| June 30, 2020 | -0.161M |
| March 31, 2020 | -0.791M |
| December 31, 2019 | -1.397M |
| September 30, 2019 | -0.982M |
| June 30, 2019 | -1.513M |
| March 31, 2019 | -1.375M |
| December 31, 2018 | -1.082M |
| September 30, 2018 | -1.609M |
| June 30, 2018 | -1.37M |
| March 31, 2018 | -1.619M |
| December 31, 2017 | -2.142M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.588M |
| June 30, 2017 | -2.695M |
| March 31, 2017 | -2.799M |
| December 31, 2016 | -4.197M |
| September 30, 2016 | -3.932M |
| June 30, 2016 | -4.064M |
| March 31, 2016 | -5.325M |
| December 31, 2015 | -4.12M |
| September 30, 2015 | -5.407M |
| June 30, 2015 | -5.946M |
| March 31, 2015 | -5.148M |
| December 31, 2014 | -6.415M |
| September 30, 2014 | -5.859M |
| June 30, 2014 | -6.102M |
| March 31, 2014 | -5.822M |
| December 31, 2013 | -5.638M |
| September 30, 2013 | -5.803M |
| June 30, 2013 | -6.122M |
| March 31, 2013 | -6.511M |
| December 31, 2012 | -6.689M |
| September 30, 2012 | -6.549M |
| June 30, 2012 | -7.453M |
| March 31, 2012 | -8.019M |
| December 31, 2011 | -6.964M |
| September 30, 2011 | -6.961M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.513M
Minimum
Jun 2019
0.929M
Maximum
Dec 2023
-0.4391M
Average
-0.411M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Armata Pharmaceuticals Inc | -47.42M |